VIENNA--(BUSINESS WIRE)--Ribbon Bio GmbH, the DNA synthesis company, today announced the launch of MiroSynth™ DNA, its first commercial product designed to meet the growing demand for complex and ...
DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...
Cell-Free DNA assembly company, Ribbon Bio, has today announced two major strategic advances designed to remove long‑standing constraints in DNA production and broaden access to high‑quality synthetic ...
Ansa Biotechnologies, Inc., the trusted partner for DNA synthesis, today announced its lineup of presentations at the ...
DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell, Bio-Medical Science Co ...
Loss of an enzyme necessary for a process called lipoylation disrupts the way cancer cells copy their DNA, increasing their ...
GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the ...
Almost 20 years ago, James Randerson ordered a sequence of smallpox DNA. Smallpox is the only human disease to have ever been successfully eradicated — 46 years ago as of yesterday. It’s one of the ...